Sensitivity and identifiability analysis of a third-order tumor growth model

The growing cancer cases attract more and more scientific research and introductions of new models, applied control algorithms and methods. The models are fundamental in the area of computer generated low-dose metronomic (LDM) chemotherapy, when the administration of the drug is ought to be optimized. Generally the in-silico tests and investigations are based on a model, which is hypothesized to describe the given process reliably and accurately. The analysis of the models and its parameters is crucial for therapy generation. We performed an analysis of a third-order tumor growth model based on sensitivity analysis and identifiability tests. The results show that a subset of parameters can be fixed as population values and the rest of the parameter sets results in an identifiable system with minor loss of accuracy.

[1]  P. Hahnfeldt,et al.  Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.

[2]  Eva Balsa-Canto,et al.  Bioinformatics Applications Note Systems Biology Genssi: a Software Toolbox for Structural Identifiability Analysis of Biological Models , 2022 .

[3]  Levente Kovács,et al.  Extended tumor growth model for combined therapy , 2019, 2019 IEEE International Conference on Systems, Man and Cybernetics (SMC).

[4]  Yan Yang,et al.  Tumour chemotherapy strategy based on impulse control theory , 2017, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[5]  Alberto Gandolfi,et al.  Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999). , 2004, Mathematical biosciences.

[6]  Gergely Szakács,et al.  Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Levente Kovács,et al.  Modeling of tumor growth incorporating the effect of pegylated liposomal doxorubicin , 2019, 2019 IEEE 23rd International Conference on Intelligent Engineering Systems (INES).

[8]  Claudio Cobelli,et al.  Controllability, Observability and Structural Identifiability of Multi Input and Multi Output Biological Compartmental Systems , 1976, IEEE Transactions on Biomedical Engineering.

[9]  Ali Cinar,et al.  Adaptive and Personalized Plasma Insulin Concentration Estimation for Artificial Pancreas Systems , 2018, Journal of diabetes science and technology.

[10]  Alejandro F. Villaverde,et al.  Identifiability of large nonlinear biochemical networks , 2016 .

[11]  Pasquale Palumbo,et al.  Optimal Impulsive Control With Application to Antiangiogenic Tumor Therapy , 2020, IEEE Transactions on Control Systems Technology.

[12]  Levente Kovács,et al.  Optimal scheduling of low-dose metronomic chemotherapy: an in-silico analysis , 2020, 2020 IEEE 15th International Conference of System of Systems Engineering (SoSE).

[13]  Eric Walter,et al.  Identification of Parametric Models: from Experimental Data , 1997 .

[14]  Levente Kovács,et al.  Tumor dynamics modeling based on formalreaction kinetics , 2019, Acta Polytechnica Hungarica.

[15]  Eva Balsa-Canto,et al.  AMIGO2, a toolbox for dynamic modeling, optimization and control in systems biology , 2016, Bioinform..